Ratings PT Medco Energi Internasional Tbk

Equities

MEDC

ID1000053705

End-of-day quote INDONESIA S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
1,425 ^IDR	-3.06%		-5.00%	+23.38%

Apr. 02	PT Medco Energi Internasional Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	PT Medco Energi Internasional Tbk completed the acquisition of 20% stake in Block 60 producing and Block 48 exploration licenses in Oman from Oq Exploration And Production.	CI

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Its low valuation, with P/E ratio at 97336.07 and 102370.69 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company appears to be poorly valued given its net asset value.
The company has a low valuation given the cash flows generated by its activity.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's earnings growth outlook lacks momentum and is a weakness.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Oil & Gas Exploration and Production

	1st Jan change	Capi.	ESG Refinitiv
PT MEDCO ENERGI INTERNASIONAL TBK	+23.38%	2.2B	-
CHEVRON CORPORATION	+10.81%	305B	A-
CONOCOPHILLIPS	+12.10%	152B	C
CNOOC LIMITED	+51.38%	120B	B+
EOG RESOURCES, INC.	+11.91%	77.86B	B-
PIONEER NATURAL RESOURCES COMPANY	+22.35%	64.28B	B-
OCCIDENTAL PETROLEUM CORPORATION	+13.68%	60.17B	C+
HESS CORPORATION	+11.99%	49.58B	A-
DIAMONDBACK ENERGY, INC.	+33.54%	36.96B	C+
WOODSIDE ENERGY GROUP LTD	-9.01%	35.29B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes